Physician

Taylor Griffin Dickerson, MD

According to 2025 Medicare claims, Taylor Dickerson, MD (NPI: 1154825974) practices dermatology in the Longview, TX market, with the plurality of this provider's patient population coming from Gregg, TX. This provider's primary affiliated billing organization is WALLIS DERMATOLOGY ASSOCIATES PLLC (NPI: 1396945234; TIN: 454041922) and primary practice location at 75605-0038.

Dickerson's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,092 traditional Medicare patients, billed 5,129 HCPCS/CPT codes, and received $321,278 in Medicare payments. The top billing code was 17110 (Destruction of skin growth, 1-14 growths). Part D data shows 1,820 prescription claims across 685 beneficiaries totaling $841,607 in drug costs, led by Rinvoq (Upadacitinib). Open Payments data shows 144 records totaling $2,925. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $1,868 to $841,607. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$161K$321K2022 Medicare payment: $76,323 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $160,812 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $321,278 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
20223851,312$76,323
20237282,937$160,812
20241,0925,129$321,278

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$421K$842K2018 Drug cost: $1,868 (USD; Tot_Drug_Cst)2019 Drug cost: $33,167 (USD; Tot_Drug_Cst)2020 Drug cost: $28,276 (USD; Tot_Drug_Cst)2021 Drug cost: $148,604 (USD; Tot_Drug_Cst)2022 Drug cost: $348,148 (USD; Tot_Drug_Cst)2023 Drug cost: $355,623 (USD; Tot_Drug_Cst)2024 Drug cost: $841,607 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
20181637$1,868
201958202$33,167
20203997$28,276
202140110$148,604
2022229515$348,148
20234271,104$355,623
20246851,820$841,607

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17110Destruction of skin growth, 1-14 growths309363$76
11102Biopsy of related skin growth, first growth305363$62
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more7911,110$59
17000Destruction of precancer skin growth, 1 growth376477$35
17003Destruction of precancer skin growth, 2-14 growths2491,308$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
RinvoqUpadacitinib26780$172,188
Cosentyx Unoready PenSecukinumab12336$103,865
Taltz AutoinjectorIxekizumab14392$99,088
Dupixent PenDupilumab12322$50,291
Clobetasol PropionateClobetasol Propionate2165,667$7,881

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.144$2,925ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Taylor Griffin Dickerson, MD?

Tedicare shows public-source Medicare data for Taylor Griffin Dickerson, MD (NPI 1154825974), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Taylor Griffin Dickerson, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Taylor Griffin Dickerson, MD?

Taylor Griffin Dickerson, MD is linked to WALLIS DERMATOLOGY ASSOCIATES PLLC (billing NPI 1396945234) in the available physician profile data.

Does Taylor Griffin Dickerson, MD have Open Payments data?

Taylor Griffin Dickerson, MD has 144 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.